Nyaradzo Chigorimbo-Tsikiwa joined the DTHC as an NRF early career fellow. She completed her post- doctoral fellowship in 2013 in Drug Discovery in which she was part of the multidisciplinary team that developed the first African clinical candidate, MMV390048 an antimalarial which was developed using modern drug discovery paradigms. She is passionate about home grown African solutions and interventions to tackle African problems. Dr Chigorimbo-Tsikiwa currently uses multidisciplinary biomedical approaches to understanding and finding solutions to prevent HIV infection. She works with Professor Linda-Gail Bekker and Professor Clive Gray, and several international collaborators.